Literature DB >> 29266345

Hyperuricaemia and development of type 2 diabetes mellitus in Asian population.

Byoung Geol Choi1, Dae Jin Kim2, Man Jong Baek3, Yang Gi Ryu3, Suhng Wook Kim2, Min Woo Lee2, Ji Young Park4, Yung-Kyun Noh5, Se Yeon Choi1, Jae Kyeong Byun1, Min Suk Shim6, Ahmed Mashaly6, Hu Li1, Yoonjee Park6, Won Young Jang6, Woohyeun Kim6, Jun Hyuk Kang6, Jah Yeon Choi6, Eun Jin Park6, Sung-Hun Park6, Sunki Lee6, Jin Oh Na6, Cheol Ung Choi6, Eung Ju Kim6, Chang Gyu Park6, Hong Seog Seo6, Dong Joo Oh6, Seung-Woon Rha6.   

Abstract

Recently, meta-analysis studies reported that hyperuricaemia is associated with higher incidence of type 2 diabetes mellitus (T2DM), however, there are limited data on the Asian population. The aim of this observational study is to estimate the long-term impact of hyperuricaemia on the new-onset T2DM and cardiovascular events. This study is based on a single-centre, all-comers, and large retrospective cohort. Subjects that visited from January 2004 to February 2014 were enrolled using the electronic database of Korea University Guro Hospital. A total of 10 505 patients without a history of T2DM were analyzed for uric acid, fasting glucose and haemoglobin (Hb) A1c level. Inclusion criteria included both Hb A1c <5.7% and fasting glucose level <100 mg/dL without T2DM. Hyperuricaemia was defined as a uric acid level ≥7.0 mg/dL in men, and ≥6.5 mg/dL in women. To adjust baseline confounders, a propensity score matching (PSM) analysis was performed. The impact of hyperuricaemia on the new-onset T2DM and cardiovascular events were compared with the non-hyperuricaemia during the 5-year clinical follow-up. After PSM, baseline characteristics of both groups were balanced. In a 5-year follow-up, the hyperuricaemia itself was a strong independent predictor of the incidence of new-onset T2DM (HR, 1.78; 95% CI, 1.12 to 2.8). Hyperuricaemia was a strong independent predictor of new-onset T2DM, which suggests a substantial implication for a correlation between uric acid concentration and insulin resistance (or insulin sensitivity). Also, hyperuricaemia is substantially implicated in cardiovascular risks and the further long-term cardiovascular events in the crude population, but it is not an independent predictor of long-term cardiovascular mortality in the matched population.
© 2017 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  diabetes mellitus; hyperuricaemia; risk factors; uric acid

Mesh:

Year:  2018        PMID: 29266345     DOI: 10.1111/1440-1681.12911

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  8 in total

1.  Sex-Specific Associations of Circulating Uric Acid with Risk of Diabetes Incidence: A Population-Based Cohort Study from Sweden.

Authors:  Ning Chen; Iram Faqir Muhammad; Zhibin Li; Peter M Nilsson; Yan Borné
Journal:  Diabetes Metab Syndr Obes       Date:  2020-11-12       Impact factor: 3.168

2.  Urinary Proteomic Characteristics of Hyperuricemia and Their Possible Links with the Occurrence of Its Concomitant Diseases.

Authors:  Shuai Huo; Hongxin Wang; Meixia Yan; Peng Xu; Tingting Song; Chuang Li; Ruimin Tian; Xiaoling Chen; Kun Bao; Ying Xie; Ping Xu; Weimin Zhu; Fengsong Liu; Wei Mao; Chen Shao
Journal:  ACS Omega       Date:  2021-03-29

3.  Uric acid lowering improves insulin sensitivity and lowers blood pressure: a meta-analysis of randomized parallel-controlled clinical trials.

Authors:  Qunchuan Zong; Guanyi Ma; Tao Wang
Journal:  Afr Health Sci       Date:  2021-03       Impact factor: 0.927

4.  Serum uric acid level and all-cause and cardiovascular mortality in peritoneal dialysis patients: A systematic review and dose-response meta-analysis of cohort studies.

Authors:  Ting Kang; Youchun Hu; Xuemin Huang; Adwoa N Amoah; Quanjun Lyu
Journal:  PLoS One       Date:  2022-02-22       Impact factor: 3.240

5.  Mediating Effect of Body Mass Index and Dyslipidemia on the Relation of Uric Acid and Type 2 Diabetes: Results From China Health and Retirement Longitudinal Study.

Authors:  Fang Cheng; Yanzhi Li; Han Zheng; Lu Tian; Hongying Jia
Journal:  Front Public Health       Date:  2022-01-28

6.  Prevalence and Risk Factors of Hyperuricemia and Gout: A Cross-sectional Survey from 31 Provinces in Mainland China.

Authors:  Jing Song; Chenye Jin; Zhongyan Shan; Weiping Teng; Jing Li
Journal:  J Transl Int Med       Date:  2022-07-07

7.  Sex-Specific Association of Serum Uric Acid Level and Change in Hyperuricemia Status with Risk of Type 2 Diabetes Mellitus: A Large Cohort Study in China.

Authors:  Yanmei Lou; Pei Qin; Changyi Wang; Jianping Ma; Xiaolin Peng; Shan Xu; Hongen Chen; Dan Zhao; Li Wang; Dechen Liu; Yang Li; Ping Zhao; Dezhu Han; Dongsheng Hu; Fulan Hu
Journal:  J Diabetes Res       Date:  2020-07-23       Impact factor: 4.011

8.  CMap analysis identifies Atractyloside as a potential drug candidate for type 2 diabetes based on integration of metabolomics and transcriptomics.

Authors:  Hailong Li; Xiaodong Shi; Hua Jiang; Junren Kang; Miao Yu; Qifei Li; Kang Yu; Zhengju Chen; Hui Pan; Wei Chen
Journal:  J Cell Mol Med       Date:  2020-05-29       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.